CA
Carisma Therapeutics, Inc.
CARM · OTC
$0.00 -12.50% (-$0.00)
1M -69.57%
Market Cap $33.5K
P/E Ratio 0.00x
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/S 0.00x
P/E 0.00x
P/B N/A
Growth
0 /100
Declining Rev. growth 9.57%
FCF growth N/A
Book val. growth N/A
Profitability
63 /100
Moderate Net margin 15.28%
Op. margin 20.61%
FCF margin 42.59%
Quality
43 /100
Average ROA 122.70%
Asset turnover 8.03x
ROIC 10,330.50%
Debt
79 /100
Low Net debt/EBITDA -0.15x
Current ratio 0.86x
Int. coverage N/A
Stability
13 /100
Unstable Rev. volatility 61.22%
EPS volatility 2,319.95%
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre CARM
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Craig R. Jalbert
Employees
46
Headquarters
Philadelphia
Evenimente viitoare
05 NOV.
Earnings
Upcoming earnings report